Radiotherapy for bladder cancer study
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies how well radiation therapy works as the main treatment for bladder cancer. It may help people who haven't had their bladder removed before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of bladder cancer called urothelial carcinoma (or a related type)
- You are receiving radiation therapy with the goal of curing the cancer (not just for pain relief)
- You have not had your bladder surgically removed (radical cystectomy)
- You are able to complete follow-up visits and provide all needed data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether focused radiation therapy directed at the bladder can help patients with muscle-invasive bladder cancer who are not candidates for surgical removal or have chosen not to have surgery. The goal is to see if this approach can control the cancer and improve quality of life.
This trial tests whether radiation therapy can help people whose bladder cancer (specifically carcinoma in situ) did not get better with BCG treatment and who are not having their bladder removed. It aims to offer a less invasive option for controlling the cancer.
This trial tests radiotherapy (high-energy X-rays) for a specific type of early-stage bladder cancer (CIS) that hasn't gone away after BCG treatment. It's for people who can't or choose not to have bladder removal surgery.
This trial tests a new online adaptive radiotherapy technique for bladder cancer that adjusts the radiation plan daily based on changes in the bladder. It aims to improve treatment accuracy and reduce side effects.
This trial tests whether adding radiation therapy to immunotherapy after bladder removal surgery can help prevent cancer from coming back. It's for people with advanced bladder cancer who have already started immunotherapy.
This trial compares radiotherapy with a radiosensitizer to BCG therapy for people with high-risk non-muscle invasive bladder cancer. The goal is to see which treatment better controls the cancer and helps patients avoid bladder removal.
Hear when a new Bladder Cancer (BC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.